ReviewAmerican journal of stem cells2018

Current approaches in regenerative medicine for the treatment of diabetes: introducing CRISPR/CAS9 technology and the case for non-embryonic stem cell therapy.

Lauren Coombe et al.PubMed ↗Full text ↗

No numbers read from the abstract.